StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Kunal Bothra

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byKunal BothraHorizon: NA (inferred Swing (≤2wk))6 Oct 2026via ET Now

Entry—Next open
Target₹1,260
Total upside —
Stop loss₹1,186—
CMP₹1,2082h ago
ActiveNA+4.30%upside left 2 wk left
Follow Kunal Bothra for new calls(32% target hit, 250 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 1 other Swing call on DRREDDYSee 169 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 6 Oct, 6:24 pm IST
5 supporting3 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·6 Oct · today

Hikma signs exclusive licensing and distribution agreement with Dr. Reddy’s Laboratories for Nicotinell across MENA

NewsGoogle News·28 Sept · 1w ago

(opens in new tab)

Dr Reddy's Laboratories stock gains as Q1 profit falls

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·23 Sept · 2w ago

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·21 Sept · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (3)

Past week's volume 2.1× the 30-day average

Technicals · volume·5 Oct · yesterday

Dr. Reddy's faces securities fraud probe after Q1 earnings hit by semaglutide batch issues.

NewsGoogle News·25 Sept · 2w ago

(opens in new tab)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·25 Sept · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Kunal Bothra

Every call and its outcome